Influence of Pathological Nodal Status and Maximal Standardized Uptake Value of the Primary Tumor and Regional Lymph Nodes on Treatment Plans in Patients With Advanced Oral Cavity Squamous Cell Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 2, 2010, Pages 421-429

  Liao, Chun Ta ^a,b   Wang, Hung Ming ^a,b   Chang, Joseph Tung Chieh ^a,b   Lin, Chien Yu ^a,b   Ng, Shu Hang ^a,b   Huang, Shiang Fu ^a,b   Chen, I How ^a,b   Hsueh, Chuen ^a,b   Lee, Li Yu ^a,b   Lin, Chih Hung ^a,b   Cheng, Ann Joy ^a,b   Yen, Tzu Chen ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

FDG PET; Oral cavity; Squamous cell carcinoma; Standardized uptake value; Survival

Indexed keywords

CLINICAL INFORMATION; COX REGRESSION ANALYSIS; CUT-OFF VALUE; DISEASE-FREE SURVIVAL; DISEASE-SPECIFIC SURVIVALS; DISTANT METASTASIS; FDG PET; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; LYMPH NODE; LYMPH NODE METASTASIS; MULTI VARIATE ANALYSIS; NODAL STATUS; ORAL CAVITY; PROGNOSTIC FACTORS; SCORING SYSTEMS; SQUAMOUS CELL CARCINOMA; STANDARDIZED UPTAKE VALUES; TREATMENT PLANS;

BODY FLUIDS; DECISION MAKING; DISEASE CONTROL; MULTIVARIANT ANALYSIS; OPTIMIZATION; PATHOLOGY; REGRESSION ANALYSIS; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FOLINIC ACID; TEGAFUR;

ADULT; ADVANCED CANCER; ARTICLE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK DISSECTION; ORAL CAVITY SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951853565     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.05.002     Document Type: Article

References (37)

1. Liao C.T., Chang J.T., Wang H.M., et al. Analysis of risk factors predictive of local tumor control in oral cavity cancer. Ann Surg Oncol 15 (2008) 915-922
2. Liao C.T., Chang J.T., Wang H.M., et al. Survival in squamous cell carcinoma of the oral cavity: Differences between pT4N0 and other stage IVA categories. Cancer 110 (2007) 564-571
3. Fleming I.D., Cooper J.S., Henson D.E., et al. AJCC cancer staging manual. 5th ed. (1997), Lippincott-Raven, Philadelphia
4. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
5. Liao C.T., Chang J.T., Wang H.M., et al. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer 107 (2006) 337-344
6. Liao C.T., Ng S.H., Chang J.T., et al. T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol 43 (2007) 570-579
7. Liao C.T., Chang J.T., Wang H.M., et al. Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 73 (2009) 764-771
8. Yen T.C., Ng K.K., Ma S.Y., et al. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. J Clin Oncol 21 (2003) 3651-3658
9. Wang H.M., Wang C.S., Chen J.S., et al. Cisplatin, tegafur, and leucovorin: A moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer 94 (2002) 2989-2995
10. Bachaud J.M., Cohen-Jonathan E., Alzieu C., et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial. Int J Radiat Oncol Biol Phys 36 (1996) 999-1004
11. Allal A.S., Slosman D.O., Kebdani T., et al. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose. Int J Radiat Oncol Biol Phys 59 (2004) 1295-1300
12. Halfpenny W., Hain S.F., Biassoni L., et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 86 (2002) 512-516
13. Suzuki H, Hasegawa Y, Terada A, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol 2009 (in press).
14. Ng S.H., Yen T.C., Chang J.T., et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 24 (2006) 4371-4376
15. Wensing B.M., Vogel W.V., Marres H.A., et al. FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 116 (2006) 809-813
16. Schoder H., Carlson D.L., Kraus D.H., et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47 (2006) 755-762
17. Ng S.H., Yen T.C., Liao C.T., et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: A prospective study of 124 patients with histologic correlation. J Nucl Med 46 (2005) 1136-1143
18. Yen T.C., Chang J.T., Ng S.H., et al. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: Comparison with head and neck CT/MRI and histopathology. J Nucl Med 46 (2005) 775-781
19. Stoeckli S.J., Steinert H., Pfaltz M., et al. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 24 (2002) 345-349
20. Nakasone Y., Inoue T., Oriuchi N., et al. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers. Ann Nucl Med 15 (2001) 505-512
21. Stuckensen T., Kovacs A.F., Adams S., et al. Staging of the neck in patients with oral cavity squamous cell carcinomas: A prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 28 (2000) 319-324
22. Myers L.L., and Wax M.K. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 27 (1998) 342-347
23. Braams J.W., Pruim J., Nikkels P.G., et al. Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT. J Nucl Med 37 (1996) 897-901
24. Kovacs A.F., Dobert N., Gaa J., et al. Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer. J Clin Oncol 22 (2004) 3973-3980
25. Kunkel M., Helisch A., Reichert T.E., et al. Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy. Oral Oncol 42 (2006) 297-305
26. Kunkel M., Forster G.J., Reichert T.E., et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: Implications for prognosis and patient management. Cancer 98 (2003) 2257-2265
27. 18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncol 39 (2003) 170-177
28. Wong R.J., Lin D.T., Schoder H., et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
29. McCollum A.D., Burrell S.C., Haddad R.I., et al. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26 (2004) 890-896
30. Yao M., Graham M.M., Hoffman H.T., et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 1001-1010
31. Lowe V.J., Dunphy F.R., Varvares M., et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 19 (1997) 666-674
32. Allal A.S., Dulguerov P., Allaoua M., et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20 (2002) 1398-1404
33. Minn H., Lapela M., Klemi P.J., et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38 (1997) 1907-1911
34. Schwartz D.L., Rajendran J., Yueh B., et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130 (2004) 1361-1367
35. Kim S.Y., Roh J.L., Kim M.R., et al. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 48 (2007) 752-757
36. Kim S.Y., Roh J.L., Kim J.S., et al. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 34 (2008) 208-215
37. 18F-FDG PET standardized uptake value of neck lymph nodes predicts neck control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys (in press).